The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

HMDB10321     [(3R,5S,8R,9S,10S,13S,14S,17S) -17-hydroxy...

Synonyms: AC1MHY5P, 3alpha-Diol G, 27195-25-1, 3,17-Androstanediol glucuronide, Androstane-3,17-diol glucuronide
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of 3-Hydroxyandrostan-17-yl-glucopyranosiduronic acid

 

High impact information on 3-Hydroxyandrostan-17-yl-glucopyranosiduronic acid

 

Biological context of 3-Hydroxyandrostan-17-yl-glucopyranosiduronic acid

 

Anatomical context of 3-Hydroxyandrostan-17-yl-glucopyranosiduronic acid

 

Associations of 3-Hydroxyandrostan-17-yl-glucopyranosiduronic acid with other chemical compounds

 

Gene context of 3-Hydroxyandrostan-17-yl-glucopyranosiduronic acid

 

Analytical, diagnostic and therapeutic context of 3-Hydroxyandrostan-17-yl-glucopyranosiduronic acid

References

  1. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. Pang, S., Wang, M., Jeffries, S., Riddick, L., Clark, A., Estrada, E. J. Clin. Endocrinol. Metab. (1992) [Pubmed]
  2. Serum 3 alpha-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy. Reiner, B.J., Donohoue, P.A., Migeon, C.J., Berkovitz, G.D. J. Clin. Endocrinol. Metab. (1989) [Pubmed]
  3. Androstane-3alpha,17beta-diol glucuronide as a steroid correlate of visceral obesity in men. Tchernof, A., Labrie, F., Bélanger, A., Prud'homme, D., Bouchard, C., Tremblay, A., Nadeau, A., Després, J.P. J. Clin. Endocrinol. Metab. (1997) [Pubmed]
  4. Serum 3 alpha-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris. Joura, E.A., Geusau, A., Schneider, B., Söregi, G., Huber, J.C. Fertil. Steril. (1996) [Pubmed]
  5. Alterations in androgen conjugate levels in women and men with alopecia. Legro, R.S., Carmina, E., Stanczyk, F.Z., Gentzschein, E., Lobo, R.A. Fertil. Steril. (1994) [Pubmed]
  6. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. Obiezu, C.V., Scorilas, A., Magklara, A., Thornton, M.H., Wang, C.Y., Stanczyk, F.Z., Diamandis, E.P. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  7. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. Pfeilschifter, J., Scheidt-Nave, C., Leidig-Bruckner, G., Woitge, H.W., Blum, W.F., Wüster, C., Haack, D., Ziegler, R. J. Clin. Endocrinol. Metab. (1996) [Pubmed]
  8. Effect of excess endogenous androgens on bone density in young women. Buchanan, J.R., Hospodar, P., Myers, C., Leuenberger, P., Demers, L.M. J. Clin. Endocrinol. Metab. (1988) [Pubmed]
  9. Plasma 3 alpha-androstanediol glucuronide in precocious adrenarche. Balducci, R., Finocchi, G., Mangiantini, A., Bianchi, P., Guglielmi, R., Toscano, V. J. Endocrinol. Invest. (1993) [Pubmed]
  10. 3 alpha-Androstanediol and 3 alpha-androstanediol glucuronide. Maternal and umbilical cord plasma concentrations in normal pregnancy. Mathur, R.S., Katikaneni, L.D., Garza, D., Moody, L.O. The Journal of reproductive medicine. (1992) [Pubmed]
  11. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel. Lemay, A., Dewailly, S.D., Grenier, R., Huard, J. J. Clin. Endocrinol. Metab. (1990) [Pubmed]
  12. Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism. Moghetti, P., Castello, R., Magnani, C.M., Tosi, F., Negri, C., Armanini, D., Bellotti, G., Muggeo, M. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
  13. Usefulness of a 12-month treatment with finasteride in idiophathic and polycystic ovary syndrome-associated hirsutism. Petrone, A., Civitillo, R.M., Galante, L., Giannotti, F., D'Antò, V., Rippa, G., Tolino, A. Clinical and experimental obstetrics & gynecology. (1999) [Pubmed]
  14. Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women. Falsetti, L., Rosina, B., De Fusco, D. Eur. J. Endocrinol. (1998) [Pubmed]
  15. Design of antiandrogens and their mechanisms of action: a case study (anandron). Raynaud, J.P., Fiet, J., Le Goff, J.M., Martin, P.M., Moguilewsky, M., Ojasoo, T. Horm. Res. (1987) [Pubmed]
  16. Altered balance between the 5 alpha-reductase and aromatase pathways of androgen metabolism during controlled ovarian hyperstimulation with human menopausal gonadotropins. Slater, C.C., Chang, L., Stanczyk, F.Z., Paulson, R.J. J. Assist. Reprod. Genet. (2001) [Pubmed]
  17. Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men. Wu, A.H., Whittemore, A.S., Kolonel, L.N., Stanczyk, F.Z., John, E.M., Gallagher, R.P., West, D.W. Cancer Epidemiol. Biomarkers Prev. (2001) [Pubmed]
 
WikiGenes - Universities